Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
NCT Number: NCT00087841
The purpose of this study is to determine the effectiveness of self-hypnotic relaxation on mental and physical distress during and after tumor treatment procedures.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Phase 2
Boston, Massachusetts, 02215, United States
Pain relievers and sedatives may have limited effectiveness and serious side effects when given to alleviate distress during minimally invasive surgical procedures. Unabated distress may interfere with the ongoing procedure and may negatively impact future interventions.
Studies have shown that nonpharmacologic analgesia in the form of self-hypnotic relaxation during invasive medical procedures significantly reduces patients' pain, anxiety, drug use, and number of complications. The long-term goal of this study is to determine whether self-hypnotic relaxation therapy can be a safe and practical method for reducing cognitive and physiologic distress associated with invasive procedures.
Participants in this study will be randomly assigned to one of three groups: a standard care group, an empathic control group, and a self-hypnotic relaxation group. The emphatic control group will meet with a clinician who will offer encouragement and support. The group assigned to self-hypnotic relaxation will read a standardized script prior to procedure. Self-report questionnaires will be used to assess pain and anxiety.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Center for Complementary and Integrative Health (NCCIH)
Nih
Midcareer Development of Nonpharmacologic Analgesia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07046949
Acute Pain, Agnosia
Rivne, Rivne Oblast, Ukraine
View Trial DetailsNCT00628901
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00361036
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Albany, New York, United States
View Trial DetailsNCT00100191
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Amsterdam, Netherlands
View Trial Details